Parse Biosciences Acquires Biomage
January 16, 2024
Parse Biosciences has acquired data analysis software company Biomage, integrating Biomage's cloud-based single-cell RNA sequencing analysis platform into Parse's product portfolio. The deal will give Parse customers access to faster, intuitive single-cell data analysis (Biomage's Cellenics/Cellscope), pairing Parse's Evercode combinatorial barcoding technology with Biomage's analysis tools to reduce analysis time and expand capabilities.
- Buyers
- Parse Biosciences
- Targets
- Biomage
- Industry
- Software
- Location
- Scotland, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
QIAGEN to Acquire Parse Biosciences
November 4, 2025
Biotechnology
QIAGEN entered into a definitive agreement to fully acquire Parse Biosciences, expanding its Sample technologies portfolio into the single-cell sequencing market. The deal is expected to close in late 2025/December 2025 for an upfront payment of approximately $225 million in cash, plus up to $55 million in milestone payments.
-
10x Genomics to Acquire Scale Biosciences
August 7, 2025
Healthcare Services
10x Genomics, Inc. has signed a definitive agreement to acquire Scale Biosciences, Inc., a single-cell analysis company. The deal is intended to expand 10x’s Chromium platform with Scale’s key inventions and technologies and broaden access to scalable single-cell analysis for researchers worldwide.
-
Ginkgo Bioworks Acquires Patch Biosciences
February 28, 2024
Biotechnology
Ginkgo Bioworks has acquired Patch Biosciences, a startup that built an AI platform for sequence design to advance genetic medicines. The acquisition will integrate Patch's machine‑learning models and validated assays into Ginkgo's platform to expand its gene therapy, cell therapy and RNA therapeutics capabilities for biopharma customers.
-
Ginkgo Bioworks Acquires Assets from Bitome
June 6, 2022
Biotechnology
Ginkgo Bioworks acquired certain assets from Bitome, a Boston-based developer of real-time metabolite monitoring technology, to integrate continuous metabolite monitoring into its cell engineering platform. The acquisition is intended to accelerate design-build-test-learn cycles and bioprocess optimization across Ginkgo’s portfolio of cell programs by providing real-time metabolic data and ML-driven insights.
-
CellCarta Acquires Biogazelle
December 14, 2021
Biotechnology
CellCarta has acquired Biogazelle, a Ghent-based leader in digital PCR (dPCR), qPCR and RNASeq assay development, to strengthen and expand its genomic capabilities. The acquisition creates a Center of Excellence for complex genomic biomarker assay development within CellCarta and broadens its service offering for pharmaceutical and biotech clients across discovery and clinical stages.
-
Bio-Rad Acquires Celsee, Inc.
April 9, 2020
Biotechnology
Bio-Rad Laboratories has acquired Celsee, Inc., a developer of instruments and consumables for single-cell isolation, detection and analysis. The acquisition expands Bio‑Rad’s capabilities in single-cell analysis and precision medicine; terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.